NO20063805L - Hoyrent butokonazolnitrat med spesifisert partikkelstorrelse og en fremgangsmate for fremstilling derav - Google Patents

Hoyrent butokonazolnitrat med spesifisert partikkelstorrelse og en fremgangsmate for fremstilling derav

Info

Publication number
NO20063805L
NO20063805L NO20063805A NO20063805A NO20063805L NO 20063805 L NO20063805 L NO 20063805L NO 20063805 A NO20063805 A NO 20063805A NO 20063805 A NO20063805 A NO 20063805A NO 20063805 L NO20063805 L NO 20063805L
Authority
NO
Norway
Prior art keywords
high purity
particle size
preparation
specified particle
butoconazole nitrate
Prior art date
Application number
NO20063805A
Other languages
English (en)
Norwegian (no)
Inventor
Laszlo Czibula
Laszlo Dobay
Eva Werkne Papp
Judit Nagyne Bagdy
Ferenc Sebok
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NO20063805L publication Critical patent/NO20063805L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20063805A 2004-01-27 2006-08-25 Hoyrent butokonazolnitrat med spesifisert partikkelstorrelse og en fremgangsmate for fremstilling derav NO20063805L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0400270A HUP0400270A3 (en) 2004-01-27 2004-01-27 High purity butoconazole nitrate having a predetermined particle size and process for the production of the same
PCT/HU2005/000002 WO2005070897A1 (fr) 2004-01-27 2005-01-25 Butoconazole nitrate de haute purete presentant une taille particulaire specifiee, et son procede de preparation

Publications (1)

Publication Number Publication Date
NO20063805L true NO20063805L (no) 2006-08-25

Family

ID=89981937

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063805A NO20063805L (no) 2004-01-27 2006-08-25 Hoyrent butokonazolnitrat med spesifisert partikkelstorrelse og en fremgangsmate for fremstilling derav

Country Status (9)

Country Link
US (1) US7625935B2 (fr)
EP (2) EP1903035A3 (fr)
JP (1) JP4795973B2 (fr)
DE (1) DE602005015417D1 (fr)
EA (1) EA009238B1 (fr)
HU (1) HUP0400270A3 (fr)
NO (1) NO20063805L (fr)
UA (1) UA87674C2 (fr)
WO (1) WO2005070897A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102649796A (zh) * 2011-02-24 2012-08-29 四川滇虹医药开发有限公司 一种硝酸布康唑中间体的制备方法
CN105198816B (zh) * 2015-10-09 2018-05-01 株洲千金药业股份有限公司 一种工业化生产硝酸布康唑的方法
CN105218455B (zh) * 2015-10-09 2018-07-03 株洲千金药业股份有限公司 一种工业化连续生产硝酸布康唑的方法
CN105175338B (zh) * 2015-10-09 2018-03-23 株洲千金药业股份有限公司 一种工业化生产硝酸布康唑中间体的方法
CN105175341B (zh) * 2015-10-09 2017-12-26 株洲千金药业股份有限公司 一种工业化合成硝酸布康唑中间体的方法
CN105198814B (zh) * 2015-10-09 2018-03-20 株洲千金药业股份有限公司 一种工业化生产硝酸布康唑中间体的方法
CN105218456B (zh) * 2015-10-09 2018-07-03 株洲千金药业股份有限公司 一种工业化生产硝酸布康唑的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL184160C (nl) * 1977-01-10 1989-05-01 Syntex Inc Tegen schimmels werkzame imidazool-derivaten, preparaten die ze bevatten en werkwijze voor de bereiding daarvan.

Also Published As

Publication number Publication date
EA009238B1 (ru) 2007-12-28
DE602005015417D1 (de) 2009-08-27
EP1903035A3 (fr) 2009-01-07
UA87674C2 (ru) 2009-08-10
EP1709005B1 (fr) 2009-07-15
JP2007519699A (ja) 2007-07-19
HUP0400270A2 (hu) 2005-12-28
HU0400270D0 (en) 2004-04-28
WO2005070897A1 (fr) 2005-08-04
EP1903035A2 (fr) 2008-03-26
US20080221190A1 (en) 2008-09-11
JP4795973B2 (ja) 2011-10-19
US7625935B2 (en) 2009-12-01
EP1709005A1 (fr) 2006-10-11
EA200601373A1 (ru) 2006-12-29
HUP0400270A3 (en) 2007-09-28

Similar Documents

Publication Publication Date Title
NO20063805L (no) Hoyrent butokonazolnitrat med spesifisert partikkelstorrelse og en fremgangsmate for fremstilling derav
NO20063517L (no) Ny krystallinsk form v av agomelatin, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
NO20064596L (no) Delta-krystallinsk form av ivabradin-hydroklorid, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
TW200640900A (en) 1-(2h)-isoquinolone derivative
WO2006024486A3 (fr) Derives amide de 3-phenyl-dihydropyrimido[4,5-d]pyrimidinones, leur fabrication et leur utilisation en tant qu'agents pharmaceutiques
NO20063516L (no) Ny krystallinsk form III av agomelatin, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
PL2018379T3 (pl) Sole skopiny oraz ich zastosowanie w sposobach wytwarzania N-demetylo-tiotropium i bromku tiotropium
UA97351C2 (ru) Производная кумарина, имеющая противоопухолевую активность
TW200640874A (en) &bgr d-crystallind form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
TW200745111A (en) New compounds
NO20050921L (no) Nye fysiologisk aktive substanser
TNSN08173A1 (en) Dispersible tablets comprising deferasirox
NO20085078L (no) Nye forbindelser
NO20060870L (no) Fluorsubstituert omega-karboksyaryldifenylurea for behandling og profylakse av sykdommer og tilstander
UA106759C2 (uk) Спосіб синтезу пірфенідону
TW200612976A (en) Peptidic vasopressin receptor agonists
PL1758852T3 (pl) Podstawione związki cyklopentenu
IL187591A0 (en) Pharmaceutical composition as solid dosage from and method for manufacturing thereof
MX2013005241A (es) Cristal de derivado de 6,7-insaturado-7-carbamoil morfinano y metodo para producir el mismo.
WO2007075838A3 (fr) Bromure de tiotropium pur et stable
EA200801508A1 (ru) ВЫСОКОЧИСТЫЙ 17α-ЦИАНОМЕТИЛ-17β-ГИДРОКСИ-ЭСТРА-4,9-ДИЕН-3-ОН И СПОСОБ ЕГО СИНТЕЗА
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
BRPI0517734A (pt) derivados de 1-[(6,7-alcoxiquinoxalinil substituìdo) aminocarbonil]-4- (hetero) arilpiperazina
EP1292303B1 (fr) Formulation pharmaceutique stable contenant du torsemide modification ii
WO2017174046A1 (fr) Formulation de citrate d'ixazomib de forme 3

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application